← All organizations
Highest phase reached
Phase 4
First clinical trial
May 1, 1993Last known activity
Sep 18, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (34 distinct, 17 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (14 own, 0 via acquisition)
Phase 2 (15 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Recent trials (31)
- NCT07085572Lead sponsorPhase 2Sep 18, 2025
- NCT07085572Sponsor investigatorPhase 2Sep 18, 2025
- NCT05809011Reponsible party - principal investigatorPhase 2/Phase 3Apr 24, 2023
- NCT05809011Lead sponsorPhase 2/Phase 3Apr 24, 2023
- NCT07232953Sponsor investigatorPhase 2Nov 10, 2022
- NCT07232953Lead sponsorPhase 2Nov 10, 2022
- NCT05913427Reponsible party - principal investigatorPhase 2Jun 8, 2022
- NCT05913427Lead sponsorPhase 2Jun 8, 2022
- NCT05913427Overall official - principal investigatorPhase 2Jun 8, 2022
- NCT05265988Sponsor investigatorPhase 2Oct 29, 2021
- NCT05265988Lead sponsorPhase 2Oct 29, 2021
- NCT05265988Overall official - principal investigatorPhase 2Oct 29, 2021
- NCT05019846Sponsor investigatorPhase 3Sep 30, 2021
- NCT05019846CollaboratorPhase 3Sep 30, 2021
- NCT04476199Overall official - principal investigatorPhase 2Nov 30, 2020
Details
- Last known activity
- Sep 18, 2025